SpliceBio has dosed the first patient in the Part B dose-expansion portion of its phase 1/2 ASTRA clinical trial ( ...

Currently, ophthalmology tops the list of specialties with the most ongoing clinical trials, followed by oncology, family practice, cardiology and gastroenterology. Nine fast facts on ongoing clinical ...

Joseph M. Coney, MD, FACS, discusses the importance of diverse representation in clinical trials for the ongoing advancement of safe and effective treatments, and underscores the need for cultivating ...

Keeping an eye on GLP-1 drug patients and preventing Toxic Anterior Segment Syndrome. “An acute postoperative non-infectious inflammatory reaction known as toxic anterior segment syndrome (TASS) can ...

BOSTON, June 24, 2025 /PRNewswire/ -- Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced the appointment of Murray A. Abramson, MD, MPH, ...

Please provide your email address to receive an email when new articles are posted on . Race and ethnicity disclosures in clinical trials increased significantly after implementation of the Final Rule ...

Please provide your email address to receive an email when new articles are posted on . We published a peer-reviewed article, “A unification theory for dry eye and blepharitis,” in Clinical ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...

Aaron Lee, MD, an associate professor of ophthalmology at University of Washington, describes how artificial intelligence (AI) is used in ophthalmology now and how it could be utilized in the future.

India accounts for over 20% of the global blind population and has the highest number of blind children worldwide. Clear ...

Durability of Nyxol’s Pupil Constricting Effects Using an Evening Dosing Regimen Informs Dosing Strategy for Phase 2 Trial in Presbyopia and Phase 3 Trial in NVD Ocuphire Invited to Present at the ...